<SEC-DOCUMENT>0001209191-18-060083-index.html : 20181127
<SEC-HEADER>0001209191-18-060083.hdr.sgml : 20181127
<ACCEPTANCE-DATETIME>20181127211100
ACCESSION NUMBER:		0001209191-18-060083
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20181127
FILED AS OF DATE:		20181127
DATE AS OF CHANGE:		20181127

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MAULDIN JOHN F
		CENTRAL INDEX KEY:			0001522480

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38519
		FILM NUMBER:		181204054

	MAIL ADDRESS:	
		STREET 1:		3204 BEVERLY DRIVE
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75205

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AgeX Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001708599
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				821436829
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
		BUSINESS PHONE:		510-521-3390

	MAIL ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
</SEC-DOCUMENT>